Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 409-420 of 5,650
Drug study icon
RecruitingNCT06248229

A study of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD).

This study is comparing Dyanavel XR with placebo for people with Fatigue, Attention Deficit Hyperactivity Disorder, or Attention Deficit Disorder. Participants receive Dyanavel XR or placebo and complete study visits and assessments.

In Rochester Hills
ADHDDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Rochester Center for Behavioral Medicine
Condition
ADHD
Drug study icon
RecruitingNCT06894212

SEP-363856 for schizophrenia

This study is recruiting in the United States and in Japan. It is testing SEP-363856 for schizophrenia.

Multiple locations, including Bentonville
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Japan
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
RecruitingNCT07040566

A study of Varenicline for E-cigarette Cessation

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Yale University
Condition
Addiction
Other study type icon
RecruitingISRCTN63222059

A study Platform of Enhanced care for Depression in Primary Care

This study is looking at care and outcomes for people with Mental and Behavioural Disorders or Depression. Some participants may receive usual care instead of the study treatment, and direct benefit is not guaranteed.

In United Kingdom
DepressionOther
Countries
United Kingdom
Sponsor
University of York (UK)
Condition
Depression
Other study type icon
RecruitingISRCTN46737488

A study platform of guided self-help for mild/moderate depression in primary care

This study is looking at whether Guided self-help for depression versus usual care can help people with Depression or Mental and Behavioural Disorders. Participants take part in Guided self-help for depression versus usual care and complete follow-up assessments.

In United Kingdom
DepressionOther
Countries
United Kingdom
Sponsor
University of Manchester (UK)
Condition
Depression
Drug study icon
RecruitingNCT07086313

EB-1020 for ADHD

This study is recruiting in Japan. It is testing EB-1020 for ADHD.

In Sapporo
ADHDDrugFrom 6 Years to 17 Years
Countries
Japan
Sponsor
Otsuka Pharmaceutical Co., Ltd.
Condition
ADHD
Other study type icon
RecruitingISRCTN23256704

A study to understand how immune function affects symptoms of psychosis

This observational study is following people with Psychosis or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United Kingdom
SchizophreniaOtherFrom 18 Years to 40 Years
Countries
United Kingdom
Sponsor
University of Bristol
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.